BBA
TTOO

Baker Bros. Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Baker Bros. Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20
Closed -$774K – 116
2018
Q2 		$774K Hold
20
– – 0.01% 108
2018
Q1 		$649K Hold
20
– – 0.01% 107
2017
Q4 		$412K Hold
20
– – ﹤0.01% 118
2017
Q3 		$420K Buy
+20
New +$371K ﹤0.01% 116

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baker Bros. Advisors's TTOO Position: Q3 2018 in Review

Baker Bros. Advisors sold out of T2 Biosystems, Inc (TTOO) in Q3 2018, closing a stake of 20 shares — an estimated $774K sold.

Baker Bros. Advisors first reported a position in TTOO in Q3 2017 and held it in 4 quarters. The position peaked at $774K in Q2 2018. 85 funds tracked by Wall St. Rank hold TTOO as of Q3 2018.

  • Baker Bros. Advisors reported no remaining T2 Biosystems, Inc position as of Q3 2018 after selling out during the quarter.
  • Baker Bros. Advisors sold 20 T2 Biosystems, Inc shares in Q3 2018, an estimated $774K.
  • Baker Bros. Advisors first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 4 quarters.
  • Baker Bros. Advisors's T2 Biosystems, Inc position peaked at $774K in Q2 2018.
  • 85 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.